Loading clinical trials...
Loading clinical trials...
OCS-Tapering-Delphi: Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma: A Delphi Consensus Study
The objectives of this study are to use the Delphi method to assemble an expert panel representing innovation in asthma treatment, to collect freely suggested recommendation statements concerning OCS tapering (and sub-topics) among severe asthma patients from this panel for peer evaluation, and finally to determine the level of consensus for each statement from the panel as a whole.
A series of anonymous questionnaires will be administered to a panel of experts. Each questionnaire administered results in a body of information that is re-presented to the experts before performing the next round. Initial brainstorming questionnaires are open in nature, and are used to generate statements that individual experts would like to see evaluated by their peers. Subsequent ranking questionnaires require that each expert rank each statement according to a pre-defined likert scale. Serial ranking questionnaires are administered electronically and continue until stopping rules are met, or the maximum number of allowed rounds is achieved (capped at three rounds for the present study). Experts are recruited by invitation or response to open call (see eligibility criteria and url at the end of this declaration.)
Age
All ages
Sex
ALL
Healthy Volunteers
No
Carey Suehs
Montpellier, France
Start Date
April 1, 2019
Primary Completion Date
September 26, 2019
Completion Date
September 26, 2019
Last Updated
March 25, 2021
140
ACTUAL participants
Brainstorming 1
OTHER
Ranking Round 1
OTHER
Ranking Round 2
OTHER
Ranking Round 3
OTHER
Lead Sponsor
University Hospital, Montpellier
Collaborators
NCT02327897
NCT07219173
NCT07486401
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions